Navigation Links
Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox
Date:9/15/2014

HAMILTON, N.J., Sept. 15, 2014 /PRNewswire-iReach/ -- On September 8, 2014, Dr. Charles Bennett, University of South Carolina, submitted a Citizen Petition to Dr. Margaret Hamburg, FDA Commissioner, asking the FDA to add another Black Box Warning to Levaquin, Cipro, and Avelox antibiotic drug labels.  This request asks for a Black Box Warning for the following psychiatric adverse events:  "toxic psychoses, hallucinations, paranoia, suicidal thoughts or acts, loss of consciousness, delirium, depressed level of consciousness, amnesia, coma, and memory impairment." 

Levaquin, Cipro, and Avelox are in a class of commonly prescribed antibiotics referred to as fluoroquinolones.  They are FDA-approved to treat both routine and serious infections, but are also commonly used for infection prevention and other uses for which the drugs have not been approved by the FDA.

The Black Box request also asks for language explaining that psychiatric adverse events "may start during treatment or may be delayed and start days, weeks, or months after the last dose."  Rachel Brummert, Executive Director of the Quinolone Vigilance Foundation, www.SaferPills.org, a non-profit organization that fosters, initiates, and funds research on fluoroquinolone toxicity, explains that this part of the requested Black Box Warning is important because fluoroquinolone antibiotic adverse events can have a delayed reaction. "Many people do not recognize that their new medical issues are related to the antibiotic they took days, weeks, or months earlier."

Also requested in the Citizen Petition is the addition of a specific heading for "Psychiatric Adverse Events" on the drug labels. "Although there are numerous psychiatric adverse events on the current fluoroquinolone drug labels, they are essentially hidden under the heading, 'Central Nervous System Effects,'" states Brummert.  "Most people would not look under 'Central Nervous System Effects' to find information about suicide, hallucinations, paranoia, or panic attacks. A specific heading for 'Psychiatric Adverse Events' is badly needed."

This Citizen Petition is based on data from the FDA Adverse Events Reporting System (FAERS), as well as data from a survey of individuals who reported having fluoroquinolone adverse events.  Based on the data from these sources, the following psychiatric adverse events, not currently on the drug labels at all, are identified in the Citizen Petition as needing to be added to the fluoroquinolone labels: "feeling abnormal, loss of consciousness, disorientation, agitation, delirium, depressed level of consciousness, amnesia, coma, disturbance in attention, panic attack, memory impairment, and nervousness." 

Dr. Bennett submitted another Citizen Petition to the FDA in June requesting a Black Box warning be added to the Levaquin label which would advise doctors and patients of possible Mitochondrial Toxicity, which has been implicated in such serious neurodegenerative diseases as Parkinson's, Alzheimer's, and ALS.  The FDA has not yet responded to this Citizen Petition.

John Fratti, FDA Patient Representative, Drug Safety, and strong advocate for additional fluoroquinolone drug warnings, stresses the importance of making the changes requested by both Citizen Petitions submitted by Dr. Bennett.  "Levaquin, Cipro, and Avelox have negatively affected thousands of individuals. These important label changes will disclose adverse events so doctors and patients can make informed decisions before they take these antibiotics." 

Brummert agrees with Fratti and states, "These drug label changes related to both possible mitochondrial toxicity and psychiatric adverse events, as outlined in the two Citizen Petitions, are needed immediately. The Quinolone Vigilance Foundation is calling on Dr. Hamburg, the FDA, and fluoroquinolone drug makers to take action now and not wait until more people suffer irreversible, but preventable harm."

Media Contact: Rachel Brummert, Quinolone Vigilance Foundation, 609-575-9839, rachel@saferpills.org

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Quinolone Vigilance Foundation
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Kalidex Introduces Novel Fluoroquinolone, KPI-10, at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
2. Pharmacovigilance Market [Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers (In-House and Contract Outsourcing] - Global Industry Analysis, Size, Share, Growth,
3. Pi2 Solutions Presents on Pharmacovigilance Literature Screening at Major European Risk Management Meeting
4. CPhI Report Indicates a Need for Greater Third Party Certification to Ensure GMP Vigilance
5. Cadence Health Foundation Commits $3.1 million To Support Services At Central DuPage Hospital and Delnor Hospital
6. Infinite Hero Foundation Announces Inaugural Veterans Innovation Summit for Investing & Technology (VISIT) to Improve the Lives of Military Veterans
7. Touro University California Garners Grant From Long Foundation
8. The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology"
9. Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation
10. Essentialis Secures Foundation for Prader-Willi Research Grant to Help Advance DCCR in the Treatment of Prader-Willi Syndrome
11. Fragile Kids Foundation Announces $125,000 Grant from the James M. Cox Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2018)... ... 2018 , ... Over the years, Eye Institute of New York has built ... services, and personalized care. The affiliation with OCLI will allow the office to further ... recently became the sixth affiliation of Spectrum Vision Partners’ managed practices since November 2017, ...
(Date:12/8/2018)... ... ... Cardiologist Ernst von Schwarz, MD says that women can experience unique warning ... by their doctors. “This can be especially dangerous in younger women who may not ... symptoms that are unique to women so they may become better advocates for themselves ...
(Date:12/6/2018)... NEW YORK (PRWEB) , ... December 06, 2018 , ... ... germs and bacteria. Paper towels are the best way to clean up (and throw ... typically re-used several times before they’re washed, which can spread germs around other kitchen ...
Breaking Medicine Technology:
(Date:12/10/2018)... ... December 10, 2018 , ... Becker's Healthcare ... health systems with great heart programs." , The hospitals named on this list ... cardiovascular surgery programs. Many institutions pioneered groundbreaking procedures and remain on the forefront ...
(Date:12/10/2018)... ... 2018 , ... Five years ago, Erica Lester was diagnosed with clinical depression. “I had what ... to pieces. I had two beautiful daughters. I had a great a job working as ... says she spent most days struggling to get out of bed. On the days ...
(Date:12/10/2018)... (PRWEB) , ... December 10, 2018 , ... ... Palm Harbor Emergency Room and Florida Hospital Wesley Chapel recently received the 2018 ... category of patient experience. The award for both emergency and inpatient services is ...
(Date:12/8/2018)... ... December 07, 2018 , ... Garland was recently ... tradition of supporting non-profit organizations through fun, creative and thoughtful fundraising. Garland’s philanthropic ... than $400,000 for charities in northeast Ohio and across the country over the ...
(Date:12/8/2018)... ... December 07, 2018 , ... Caring.com, the nation’s most visited website for senior ... alert systems, to its list of top medical alert systems for 2019. The medical ... Guardian was one of fourteen companies that qualified for the list based on its ...
Breaking Medicine News(10 mins):